Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1980 Jul;35(7):500–505. doi: 10.1136/thx.35.7.500

Immunological state of patients with carcinoma of the bronchus before and after radiotherapy.

A M Savage, J A Pritchard, T J Deeley, B H Davies
PMCID: PMC471321  PMID: 7434311

Abstract

The immunological state of 30 patients with carcinoma of the bronchus was assessed before and after radiotherapy by lymphocyte response to PHA and E and EAC rosette formation. The results were compared with those from age-matched patients with benign chest disease and a group of healthy control subjects. Differences were found between the three groups and decreased immunological responses were found to correlate with shorter survival times for patients with cancer of the bronchus. These differences were not associated with the extent of the disease, or with the smoking habits of the patients. Significant differences in percentage EAC cell rosetting were demonstrated between lymphocytes from patients with malignant disease (31.3 +/- 2.0) and those for control groups (21.5 +/- 1.9 and 24.0 +/- 2.2). Cancer patients and benign chest disease patients both had significantly decreased mean E rosetting values (59.3% and 55.6%) compared with healthy control subjects (69.7%). The group of cancer patients with a normal percentage of T lymphocytes and total number of lymphocytes after radiotherapy, or those with low percentage EAC cell rosettes, had a greater than 80% survival after seven months compared with less than 50% for the rest of the patients with carcinoma of the bronchus.

Full text

PDF
503

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anthony H. M., Kirk J. A., Madsen K. E., Mason M. K., Templeman G. H. E and EAC rosetting lymphocytes in patients with carcinoma of bronchus I. Some parameters of the test and of its prognostic significance. Clin Exp Immunol. 1975 Apr;20(1):29–40. [PMC free article] [PubMed] [Google Scholar]
  2. Byfield P. E., Stratton J. A., Small R. Letter: Lymphocyte response after radiotherapy. Lancet. 1974 Feb 23;1(7852):309–309. doi: 10.1016/s0140-6736(74)92611-7. [DOI] [PubMed] [Google Scholar]
  3. Catalona W. J., Tarpley J. L., Potvin C., Chretien P. B. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes. Clin Exp Immunol. 1975 Feb;19(2):327–333. [PMC free article] [PubMed] [Google Scholar]
  4. Chretien P. B., Crowder W. L., Gertner H. R., Sample W. F., Catalona W. J. Correlation of preoperative lymphocyte reactivity with the clinical course of cancer patients. Surg Gynecol Obstet. 1973 Mar;136(3):380–384. [PubMed] [Google Scholar]
  5. Deegan M. J., Coulthard S. W., Quaiman S. J., Schork M. A. A correlative analysis of in vitro parameters of cellular immunity in patients with squamous cell carcinoma of the head and neck. Cancer Res. 1977 Dec;37(12):4475–4481. [PubMed] [Google Scholar]
  6. Dellon A. L., Potvin C., Chretien P. B. Thymus-dependent lymphocyte levels in bronchogenic carcinoma: correlations with histology, clinical stage, and clinical course after surgical treatment. Cancer. 1975 Mar;35(3):687–694. doi: 10.1002/1097-0142(197503)35:3<687::aid-cncr2820350322>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  7. Garrioch D. B., Good R. A., Gatti R. A. Lymphocyte response to P.H.A. in patients with non-lymphoid tumours. Lancet. 1970 Mar 21;1(7647):618–618. doi: 10.1016/s0140-6736(70)91658-2. [DOI] [PubMed] [Google Scholar]
  8. Jenkins V. K., Ray P., Ellis H. N., Griffiths C. M., Perry R. R., Olson M. H. Lymphocyte response in patients with head and neck cancer: effect of clinical stage and radiotherapy. Arch Otolaryngol. 1976 Oct;102(10):596–600. doi: 10.1001/archotol.1976.00780150064003. [DOI] [PubMed] [Google Scholar]
  9. Jerrells T. R., Dean J. H., Herberman R. B. Relationship between T lymphocyte levels and lymphoproliferative responses to mitogens and alloantigens in lung and breast cancer patients. Int J Cancer. 1978 Mar 15;21(3):282–290. doi: 10.1002/ijc.2910210306. [DOI] [PubMed] [Google Scholar]
  10. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
  11. Nordman E., Toivanen A. Effects of irradiation on the immune function in patients with mammary, pulmonary or head and neck carcinoma. Acta Radiol Oncol Radiat Phys Biol. 1978;17(1):3–9. doi: 10.3109/02841867809127685. [DOI] [PubMed] [Google Scholar]
  12. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Raben M., Walach N., Galili U., Schlesinger M. The effect of radiation therapy on lymphocyte subpopulations in cancer patients. Cancer. 1976 Mar;37(3):1417–1421. doi: 10.1002/1097-0142(197603)37:3<1417::aid-cncr2820370324>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  14. Riesco A. Five-year cancer cure: relation to total amount of peripheral lymphocytes and neutrophils. Cancer. 1970 Jan;25(1):135–140. doi: 10.1002/1097-0142(197001)25:1<135::aid-cncr2820250120>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  15. Roth J. A., Eilber F. R., Morton D. L. Effect of adriamycin and high-dose methotrexate chemotherapy on in vivo and in vitro cell-mediated immunity in cancer patients. Cancer. 1978 Mar;41(3):814–819. doi: 10.1002/1097-0142(197803)41:3<814::aid-cncr2820410305>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  16. Wanebo H. J., Rao B., Miyazawa N., Martini N., Middleman M. P., Oettgen H. F., Beattie E. J., Jr Immune reactivity in primary carcinoma of the lung and its relation to prognosis. J Thorac Cardiovasc Surg. 1976 Sep;72(3):339–350. [PubMed] [Google Scholar]
  17. Wood S. E., Campbell J. B., Anderson J. M., Kelly F. Letter: Lymphocyte response after radiotherapy. Lancet. 1974 May 4;1(7862):863–863. doi: 10.1016/s0140-6736(74)90506-6. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES